AbbVie breaks ground on a new central research building, “LUnA” (LUdwighafens neue Arbeitswelt) and is investing approximately €150 million in its second largest R&D location worldwide. A state-of-the-art research and laboratory building is being built on the main campus and will be home to more than 300 researchers and scientists. The facility will be built with…
Abdi Ibrahim Pharmaceuticals forms a joint venture with Cigalah Healthcare, laying the foundation for expansion into Saudi Arabia and beyond, prioritizing exports as the initial step. Through the partnership with Cigalah Healthcare, a leading pharmaceutical and consumer health company in…
Viatris today announced that Corinne M. Le Goff has joined the company as Chief Commercial Officer and will become a member of the company’s Executive Leadership Team, effective today. Le Goff is an accomplished biotechnology and pharmaceutical executive with more…
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the…
FundaMental Pharma, a neuroscience company developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases, announced the appointment of Dr. Dirk Beher as Chief Executive Officer and Executive Board member. Dr. Beher assumes this role from…
Vertex Pharmaceuticals and Alpine Immune Sciences, a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share or approximately…
Johnson & Johnson and Shockwave Medical today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an enterprise value of…
3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company. Solventum is listed on the New York Stock Exchange as SOLV. “This is an important day for 3M and Solventum, and…
Nazli Sahafi has been appointed as the General Manager of Roche Diagnostics Türkiye, Head of the Türkiye, Central Asia and Caucasian Countries Management Center, as of April 1, 2024. Nazli Sahafi, who started her career as a researcher and scientist…
Roche announced the U.S. Food and Drug Administration (FDA) approval of the cobas® Malaria test for use on the cobas® 6800/8800 Systems. This approved test can aid healthcare professionals in reducing potential risks of patient infection from transfused blood products.…